0054-0497 : Everolimus 7.5 mg Oral Tablet


NDC: 0054-0497
Labeler: Hikma Pharmaceuticals USA Inc.
Product Type: Human Prescription Drug
Drug Name:  Everolimus
Dosage Form: Oral Tablet
Application #: ANDA207486
Rev. Date: 


Appearance:


Markings: 54;627
Shapes:  Capsule
Colors:  White
Size (mm): 14
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0054-0497-13: 30 TABLET IN 1 BOTTLE (0054‑0497‑13)
  • 0054-0497-14: 1 BLISTER PACK IN 1 CARTON (0054‑0497‑14) > 28 TABLET IN 1 BLISTER PACK

Active Ingredients:

  • Everolimus

Dosage Strength:

  • 7.5 mg

Inactive Ingredients:

  • Butylated Hydroxytoluene
  • Crospovidone (15 Mpa.s At 5%)
  • Hypromellose 2910 (5 Mpa.s)
  • Anhydrous Lactose
  • Magnesium Stearate /

Pharmaceutical Classes:

  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Decreased Immunologic Activity [PE]
  • Kinase Inhibitor [EPC]
  • P-Glycoprotein Inhibitors [MoA]
  • Protein Kinase Inhibitors [MoA]
  • mTOR Inhibitor Immunosuppressant [EPC]
  • mTOR Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0054-0470 Everolimus .25 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0471 Everolimus .5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0472 Everolimus .75 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0480 Everolimus 2.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0481 Everolimus 5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0482 Everolimus 10 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0604 Everolimus 1 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0093-7766 Everolimus 2.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7767 Everolimus 5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7768 Everolimus 7.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7769 Everolimus 10 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0378-0005 Everolimus 2 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
  • 0378-0006 Everolimus 3 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
  • 0378-0007 Everolimus 5 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
  • 0378-3096 Everolimus 2.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3097 Everolimus 5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3098 Everolimus 7.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3099 Everolimus 10 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 49884-119 Everolimus 2.5 mg Oral Tablet by Par Pharmaceutical, Inc.
  • 49884-125 Everolimus 5 mg Oral Tablet by Par Pharmaceutical, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0054-0497 QR Code

< Prev: 0054-0482Next: 0054-0508 >

Related Discussions:

Everolimus Face Rash
Side Effects of Everolimus including face and body rash; swollen feet...
Everolimus Side Effects
Everolimus Side Effects: Face and Body Rash...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.